Alliance Pharma to present at the London Biotech Investment Forum at
the London Stock Exchange 

Alliance Pharma plc (AIM: APH), an emerging speciality pharmaceutical company, announces that John Dawson, the Company’s Chief Executive, will today make a presentation at the London Biotech Investment Forum, a one-day conference being held at the London Stock Exchange.

Mr Dawson’s presentation will focus on the Company’s business model, in which a stable of cash generative products provides the cash flow for investment in new opportunities, and on the Company’s late stage portfolio, including Posidorm™, the Company’s new therapy for sleep disorders.

A copy of the presentation can be seen on the Company’s website at www.alliancepharma.co.uk

For further information:

Alliance Pharma plc             + 44 (0) 1249 466966     
John Dawson, Chief Executive 
Maddy Scott, Finance Director 
www.alliancepharma.co.uk

Buchanan Communications     + 44 (0) 20 7466 5000
Mark Court/Lisa Baderoon/Rebecca Skye Dietrich